Home  /  Resource Library  /  LISOCABTAGENE MARALEUCEL IN R/R FL (TRANSCEND FL): IMPACT OF PRIOR LINES OF THERAPY, BENDAMUSTINE EXPOSURE, AND DISEASE PROGRESSION < 24 MONTHS OF INITIAL SYSTEMIC THERAPY

LISOCABTAGENE MARALEUCEL IN R/R FL (TRANSCEND FL): IMPACT OF PRIOR LINES OF THERAPY, BENDAMUSTINE EXPOSURE, AND DISEASE PROGRESSION < 24 MONTHS OF INITIAL SYSTEMIC THERAPY

ICML 2025